Management of gout in general practice—a systematic review

详细信息    查看全文

• 作者：Andrew Jeyaruban ; Sarah Larkins ; Muriel Soden
• 关键词：Allopurinol ; General practice ; Gout ; Management of gout
• 刊名：Clinical Rheumatology
• 出版年：2015
• 出版时间：January 2015
• 年：2015
• 卷：34
• 期：1
• 页码：9-16
• 全文大小：216 KB
• 参考文献：1. Arromdee E, Michet CJ, Crowson CS, O'Fallon WM, Gabriel SE (2002) Epidemiology of gout: is the incidence rising? The J Rheumatol 29(11):2403-406
  2. Klemp P, Stansfield SA, Castle B, Robertson MC (1997) Gout is on the increase in New Zealand. Ann Rheum Dis 56(1):22-6 CrossRef
  3. Owens D, Whelan B, McCarthy G (2008) A survey of the management of gout in primary care. Ir Med J 101(5):147-49
  4. Terkeltaub R (2010) Update on gout: new therapeutic strategies and options. Nat Rev Rheumatol 6(1):30-8 CrossRef
  5. Gout. Therapeutic Guidelines. 2010
  6. Zhang W, Doherty M, Bardin T, Pascual E, Barskova V, Conaghan P et al (2006) EULAR evidence based recommendations for gout. Part II: management. Report of a task force of the EULAR standing committee for international clinical studies including therapeutics (ESCISIT). Ann Rheum Dis 65(10):1312-324 CrossRef
  7. Smith P, Karlson N, Nair BR (2000) Quality use of allopurinol in the elderly. J Qual Clin Pract 20(1):42-3 CrossRef
  8. McClintock AD, Egan AJ, Woods DJ, Pillans PI (1995) A survey of allopurinol dosage prescribing. The NZ Medical J 108(1006):346-47
  9. Neogi T, Hunter DJ, Chaisson CE, Allensworth-Davies D, Zhang Y (2006) Frequency and predictors of inappropriate management of recurrent gout attacks in a longitudinal study. The J Rheumatol 33(1):104-09
  10. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P (2010) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg 8(5):336-41 CrossRef
  11. Harrold LR, Mazor KM, Velten S, Ockene IS, Yood RA (2010) Patients and providers view gout differently: a qualitative study. Chronic Illness 6(4):263-71 CrossRef
  12. M; T, k M (2013) Gouty arthritis: an approach for general practice. South African Family Practice;55 (4)
  13. Pascual E, Sivera F (2007) Why is gout so poorly managed? Ann Rheum Dis 66(10):1269-270 CrossRef
  14. Perry ME, Madhok R (2010) Treatment failure gout: failure to treat? Rheumatology 49(12):2233-234 CrossRef
  15. Shulten P, Thomas J, Miller M, Smith M, Ahern M (2009) The role of diet in the management of gout: a comparison of knowledge and attitudes to current evidence. J Human Nutr and Diet : The Off J The Br Diet Asso 22(1):3-1 CrossRef
  16. Fara N, Vazquez Mellado J, Sequeira G, Kerzberg E (2012) A survey on the current evaluation and treatment of gout in Buenos Aires. Argent Reumatol Clin 8(6):306-09 CrossRef
  17. Fraser RC, Davis RH, Walker FS (1987) Comparative trial of azapropazone and indomethacin plus allopurinol in acute gout and hyperuricaemia. The J The R Coll Gen Pract 37(302):409-11
  18. Hanly JG, Skedgel C, Sketris I, Cooke C, Linehan T, Thompson K et al (2009) Gout in the elderly—a population health study. The J Rheumatol 36(4):822-30 CrossRef
  19. Harrold LR, Mazor KM, Peterson D, Naz N, Firneno C, Yood RA (2012) Patients-knowledge and beliefs concerning gout and its treatment: a population based study. BMC Musculoskelet Disord 13:180 CrossRef
  20. Medellin MV, Erickson AR, Enzenauer RJ (1997) Variability of treatment for gouty arthritis between rheumatologists and primary care physicians. J Clin Rheumatol: Pract Rep on Rheum & Musculoskelet Dis 3(1):24-7 CrossRef
  21. Goldfien RD, Ng MS, Yip G, Hwe A, Jacobson A, Pressman A et al (2014) Effectiveness of a pharmacist-based
• 刊物类别：Medicine
• 刊物主题：Medicine & Public Health
  Rheumatology
  
• 出版者：Springer London
• ISSN：1434-9949

文摘

This systematic review aims to summarise published evidence that assessed the management of gout in regard to the following: prescription of urate lowering therapy (ULT), monitoring of serum urate levels (sUA) and allopurinol dosing in patients with renal impairment, lifestyle advice and acute management of gout. Studies investigating the management of gout in general practice (GP) were identified by searching PubMed and Scopus databases. To be eligible for inclusion, studies had to be focused on the GP setting alone. Studies were also excluded if they examined diagnosis without exploring management of gout. Editorials and reviews were excluded. A total of nine studies were identified. Eight studies explored the proportion of gout patients currently on ULT. Six out of the eight studies revealed that ULT was prescribed in less than 50?% of gout patients. Four studies considered the monitoring of sUA levels in gout patients. The results were generally similar throughout studies indicating sub-optimal management. Only two studies examined the monitoring of sUA levels specifically in patients who were prescribed ULT. The two studies showed 28 and 38?% of patients on ULT had their sUA levels monitored. Two studies examined the dosing of allopurinol in renally impaired patients and revealed that 74-8?% of renally impaired patients had an appropriate allopurinol dose of less than 300?mg. This systematic review suggests that gout is sub-optimally managed in general practice. However, more studies with a larger sample size focusing on active patients are required to provide more definitive evidence.